Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Gross Profit 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Insight Molecular Diagnostics Inc. gross profit for the quarter ending March 31, 2026 was 15000, a 98.87% decrease year-over-year.
- Insight Molecular Diagnostics Inc. gross profit for the twelve months ending March 31, 2026 was 1.8 M, a 365.39% increase year-over-year.
- Insight Molecular Diagnostics Inc. annual gross profit for 2025 was 2.3 M, a 210.54% increase from 2024.
- Insight Molecular Diagnostics Inc. annual gross profit for 2024 was 740000, a 79.18% increase from 2023.
- Insight Molecular Diagnostics Inc. annual gross profit for 2023 was 413000, a 2394.44% decrease from 2022.
- Insight Molecular Diagnostics Inc. annual gross profit for 2022 was -18000.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Insight Molecular Diagnostics Inc. Gross Profit — FAQ
Insight Molecular Diagnostics Inc. (IMDX) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Insight Molecular Diagnostics Inc.'s gross profit?
Insight Molecular Diagnostics Inc. (IMDX) reported gross profit of $2M for fiscal 2025.
Where can I see IMDX's gross profit history?
The chart and table above show Insight Molecular Diagnostics Inc.'s gross profit by year and by quarter, including the growth rate.